Kirk Tanner
Company: National Brain Tumor Society
Job title: CSO and SVP Brain Tumor Investment Fund
Seminars:
Panel Discussion: Unifying the Voice & the Impact of Stakeholders to Accelerate LBx Application, Approval & Reimbursement Path Across the Continuum of Patient Care 3:30 pm
Inspiring a discussion to unite stakeholders on the collaborations needed to identifying a robust and accelerated path to make liquid biopsy application, approval and reimbursement a reality across the continuum of patient care Understanding what does the future hold for liquid biopsy and where change and innovation need to come from to make meaningful directional…Read more
day: Day Two PM
Leveraging the Utilization of Liquid Biopsy in CNS Tumors to Measure Circulating Tumor Biomarkers 2:30 pm
Summarising the landscape of liquid biopsy in CNS tumors Highlighting the challenges and opportunities of integrating liquid biopsy in brain tumors due to the blood-brain barrier Elevating the use of liquid biopsy for monitoring tumor progression and response to therapiesRead more
day: Day One Track A PM
Paving the Path Towards Standardized Pre- Analytical Approaches in Liquid Biopsy 11:15 am
day: Day Two Track A AM